主动脉内球囊反搏术治疗急性冠脉综合征伴心源性休克的应用

目的：评价急性冠脉综合征（ACS）合并心源性休克的患者行冠脉介入治疗辅以主动脉内球囊反搏（IABP）术的安全性及有效性。方法：40例ACS合并心源性休克患者，行冠脉介入治疗辅以主动脉内球囊反搏（IABP）术，观察其临床效果及安全性。结果：40例ACS患者经冠脉介入及IABP治疗后，35例存活患者主动脉内收缩压、舒张压显著升高，分别由术前（82．54±5．35）mmHg、（50．34±3．57）mmHg上升至术后（95．11±6．87）mmHg、（80．39±4．86）mmHg（P均〈0．01）。临床症状明显好转，血流动力学显著改善。结论：急性冠脉综合征合并心源性休克患者行冠脉介入治疗时，联合应用主动脉内球囊反搏，可增加冠脉介入治疗安全性，降低病死率，提高手术成功率。

Application of intra-aortic balloon counterpuisation in patients with acute coronary syndrome compli-cated cardiogenic shock

Objective： To evaluate the safety and efficacy of percutaneous coronary intervention （PCI） with intra-aortic balloon counterpulsation （IABP） in patients with acute coronary syndrome （ACS） complicated eardiogenic shock （CS）. Methods： A total of 40 ACS ＋ CS patients received PCI supplemented by IABP. Its clinical effect and safety were observed. Results： After PCI and IABP treatment, aortic systolic blood pressure and diastolic blood pressure significantly increased [from preoperative （82.54 ± 5.35） mmHg, （50.34 ± 3.57） mmHg to postoperative （95.11 ± 6. 87） mmHg, （80.39 ± 4. 86） mmHg respectively], P〈0.01 both in 35 survived patients. Their clinical symptoms and hemodynamics significantly improved. Conclusion： Combined application of IABP during PCI can in- crease success rate, safety of PCI and decrease mortality rate in patients with ACS complicated cardiogenic shock.